Crinetics Pharmaceuticals, Inc. (CRNX)
NGS · Common · CUSIP 22663K107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CRNX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
22663K107
Market Cap
Mid Cap · $521 Million
IPO
7/17/2018 · $17.00/share
Business: Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Company Contact

CEO
R. Scott Struthers, Ph.D.
CFO
Marc Wilson
Headquarters
10222 Barnes Canyon Road, Bldg. #2, San Diego, CA 92121
Phone
858-450-6464
Investor Relations
Marc Wilson · 858-450-6464 · IR@crinetics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »